CBL — Control Bionics Share News
0.000.00%
Last trade - 00:00- AU$23.07m
- AU$21.61m
- AU$5.40m
Brief: Control Bionics Sees FY27 Revenue Growth Of 50% Over FY26
Brief: Control Bionics Says Medicare Billing Code Secured For Nextlevel Speech Devices
Brief: Control Bionics Receives UK MHRA Registration For Neurostrip
Australia's Control Bionics jumps after FDA listing for NeuroStrip device
Brief: Control Bionics Completes US FDA Registration, Device Listing For Neurostrip
Brief: Control Bionics Says Trading Halt
Brief: Control Bionics Announces First U.S. Letter Of Intent For Ios Speech Device Program
Australia's Control Bionics extends gains to second session on distribution deal
Australia's Control Bionics rises on US distribution deal
Brief: Control Bionics Signs U.S. Distribution Agreement With PRC-Saltillo
Brief: Control Bionics Signs Deal With Tobii Dynavox
Brief: Control Bionics Raises A$3.25 Million At A$0.065 Per Share
Brief: Control Bionics Says Non-Renounceable Rights Issue Offer
Australia's Control Bionics rises on upbeat revenue
Brief: Control Bionics Posts YTD Unaudited Rev To 31 May 2025 A$5.4M
Brief: Control Bionics Says Raised A$2.0 Mln Via Private Placement At A$0.045 Per Share
Australia's Control Bionics gains on premium placement
Brief: Control Bionics Says Roger Hawke Has Resigned As Chairman
Brief: Control Bionics Anticipates U.S. Revenue For 1H Will Exceed By More Than 15%